The Role of Vardenafil in Sexual Performance

Wade A, Michael Lemming O, Bang Hedegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.

What are Premature Ejaculation Pills?

In vivo evaluation of serotonergic agents and alpha-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. Compliance with fluoxetine use in men with primary premature ejaculation. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of super tadapox 100mg premature ejaculation.

Corresponding author

Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Andersen P. Sanchez C, Brennum L. The S-enantiomer of citalopram (Lu 26-054) is a highly selective and potent serotonin reuptake inhibitor. Rosenthal MH, Li D Efficacy and tolerability of escitalopram in patients intolerant of other SSRIs. Safarinejad MR. Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. The use of escitalopram in treatment of patients with premature ejaculation: a randomized, double-blind, placebo-controlled study. Arafa M, Shamloul R. A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire. Sertraline versus other antidepressive agents for depression. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Arafa M, Shamloul R. Efficacy of sertraline hydrochloride in treatment of premature ejaculation: a placebo-controlled study using a validated questionnaire. An improved dosage regimen of sertraline hydrochloride in the treatment for premature ejaculation: an 8-week, single-blind, randomized controlled study followed by a 4-week, open-label extension study.

Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.

LinkOut - more resources

Albert PR, Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients.

What you can do in the meantime

Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Greenier E, Lukyanova V, Reede L. Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions. Fluoxetine in Alzheimer’s disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for ‘on-demand’ treatment of premature ejaculation. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. 2010;7(1 Pt 1):256–268. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Dapoxetine: a new option in the medical management of premature ejaculation.

• Vardenafil is a selective PDE5 inhibitor that can influence sexual performance.
• It may have off-label benefits for premature ejaculation.
• Use cautiously if you have cardiovascular issues.
• Some men combine Vardenafil with delay creams or behavioral therapy.
• Its onset of action is typically around 30-60 minutes.
• Some users find it helpful in reducing PE severity.
• The medication should be tested in a safe environment first.
• Do not exceed recommended dosage to avoid adverse effects.
• Effects last for several hours, providing flexibility.
• It is important to manage expectations realistically.
• Use only under medical supervision for off-label purposes.
• Store in a cool, dry place away from direct sunlight.

Comparison of the clinical efficacy ceridaviescampaigner co uk and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation. Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine. Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Kasper S, Resinger E. Panic disorder: the cenforce100 place of benzodiazepines and selective serotonin reuptake inhibitors. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Re: efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. Clinical study of SS-cream in patients with lifelong premature ejaculation. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Penile vibratory threshold changes with various doses of SS-cream in patients with primary premature ejaculation.

Other treatments against premature ejaculation

Clomipramine in the treatment of rapid (premature) ejaculation. Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study. Balon R.

Tadalafil (Cialis®) for PE

Antidepressants in the treatment of premature ejaculation. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice. Dinsmore WW, Wyllie MG.

PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. [Clinical study of sildenafil in the treatment of premature ejaculation complicated by erectile dysfunction]. Clinical efficacy of Viagra with behavior therapy against premature ejaculation. Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation.

Counseling and Sex Therapy

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. Comparison of sertraline and citalopram for treatment of premature ejaculation. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire.

Efficacy of escitalopram in treatment of PE

A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. Dadfar MR, Baghinia MR. Salvage use of citalopram for treatment of fluoxetine-resistant premature ejaculation in recently married men: a prospective clinical trial. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Dell’Atti L, Galosi AB, Ippolito C. A randomized single-center study to compare the efficacy and tolerability of tadalafil once daily plus lidocaine anesthetic spray on premature ejaculation. Tramadol HCL has promise in on-demand use to treat premature ejaculation.

[Safety and efficacy of tramadol hydrochloride with behavioral modification in the treatment of premature ejaculation]. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes.

• Vardenafil is primarily used for ED, but may impact ejaculation timing.
• Vardenafil can sometimes prolong the time before ejaculation.
• It works by increasing blood flow, possibly affecting ejaculatory control.
• Not approved specifically for premature ejaculation but used off-label.
• Combining Vardenafil with behavioral therapy may improve results.
• Possible side effects include headache, flushing, and nasal congestion.
• Using Vardenafil without medical guidance can be risky.
• It may interact with other medications, altering effectiveness or safety.
• Dose optimization is important to manage side effects and efficacy.
• Vardenafil requires careful timing relative to sexual activity.
• Not a cure for PE but can help some men delay ejaculation.
• Medical consultation is essential before using Vardenafil for PE.